Abstract: This invention relates to bacteria of the genus Pseudoxanthomonas and in particular the strain deposited on Jul. 12, 2012 at the Pasteur Institute (CNCM, 25 rue du Docteur Roux, F-75724 PARIS Cedex 15, France) under No. CNCM 1-4657, capable of degrading MTBE and/or TBA. The invention also relates to a process for treatment of an effluent comprising MTBE and optionally TBA using such bacteria.

Abstract: This invention relates to bacteria of the genus Pseudoxanthomonas and in particular the strain deposited on Jul. 12, 2012 at the Pasteur Institute (CNCM, 25 rue du Docteur Roux, F-75724 PARIS Cedex 15, France) under No. CNCM 1-4657, capable of degrading MTBE and/or TBA. The invention also relates to a process for treatment of an effluent comprising MTBE and optionally TBA using such bacteria.

Abstract: This invention relates to bacteria of the genus Pseudonocardia, and in particular the strain deposited on Jul. 12, 2012 at the Pasteur Institute (CNCM, 25 rue du Docteur Roux, F-75724 PARIS Cedex 15, France) under No. CNCM 1-4656, capable of degrading MTBE and/or ETBE. The invention also relates to a process for treatment of an effluent comprising MTBE and/or ETBE and optionally TBA that uses such bacteria.

Abstract: This invention relates to new Rhodococcus wratislaviensis CNCM I-4088 bacteria or Rhodococcus aetherivorans CNCM I-4089 bacteria that can degrade multiple petroleum compounds in solution in aqueous effluents. The invention also relates to a process for treating aqueous effluents comprising a complex mixture of substances containing native hydrocarbons of gasolines and additives that are present in gasolines or diesel fuel, in which process said bacteria are grown under aerobic conditions in the presence of a growth substrate containing said mixture as a carbon source, and said mixture is at least partially degraded by the bacteria down to the final degradation products—carbon dioxide, water and biomass.

Abstract: The invention concerns an isolated or purified polypeptide having an activity in the MTBE degradation path, and/or at least one of the catabolic intermediates of MTBE, preferably selected from the group consisting of tert-butyl alcohol (TBA), 2-methyl 1,2-propanediol (2-M1, 2-PD), hydroxyisobutyraldehyde, hydroxyiso-butyric acid (HIBA), said polypeptide being selected from the group consisting of: a) a polypeptide comprising a sequence of amino acids selected from the group consisting of SEQ ID NO:2, SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:8 or SEQ ID NO:10; b) a polypeptide comprising a sequence of amino acids having at least 70% identity, preferably 75%, 80%, 90%, 95%, 98% or 99% with the sequence of amino acids of a polypeptide as defined in a); a polypeptide as defined in a) or b) whereof the sequence of amino acids comprises a substitution, deletion, insertion, addition or mutation of one or several amino acids over its entire length.

Abstract: The invention concerns an isolated or purified polypeptide having an activity in the MTBE degradation path, and/or at least one of the catabolic intermediates of MTBE, preferably selected from the group consisting of tert-butyl alcohol (TBA), 2-methyl 1,2-propanediol (2-M1, 2-PD), hydroxyisobutyraldehyde, hydroxyiso-butyric acid (HIBA), said polypeptide being selected from the group consisting of: a) a polypeptide comprising a sequence of amino acids selected from the group consisting of SEQ ID NO:2, SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:8 or SEQ ID NO:10; b) a polypeptide comprising a sequence of amino acids having at least 70% identity, preferably 75%, 80%, 90%, 95%, 98% or 99% with the sequence of amino acids of a polypeptide as defined in a); a polypeptide as defined in a) or b) whereof the sequence of amino acids comprises a substitution, deletion, insertion, addition or mutation of one or several amino acids over its entire length.